Screening of the early growth response 2 gene in Japanese patients with Charcot-Marie-Tooth disease type 1

Journal of the Neurological Sciences

Volumn 210, Issue 1-2, 2003, Pages 61-64

  Numakura, Chikahiko ^a   Shirahata, Emi ^a   Yamashita, Sumimasa ^b   Kanai, Masayo ^a   Kijima, Kazuki ^a   Matsuki, Takasumi ^c   Hayasaka, Kiyoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Charcot Marie Tooth disease; Congenital hypomyelination; Dejerine Sottas syndrome; DGGE; EGR2; HMSN

Indexed keywords

ASPARTIC ACID; EARLY GROWTH RESPONSE 2 PROTEIN; META TYROSINE; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE SEVERITY; GENE; GENE DUPLICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL;

EID: 0037962923     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00028-5     Document Type: Article

References (26)

1. Dyck P.J., Chance P., Lebo R., Carney J.A. Hereditary motor and sensory neuropathies. Dyck P.J., Thomas P.K., Griffin J.W., Low P.A., Poduslo J.F. Peripheral neuropathy. 1993;1096-1136 Saunders, Philadelphia.
2. Hayasaka K., Himoro M., Sawaishi Y., Nanao K., Takahashi T., Takada G.et al. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat. Genet. 5:1993;266-268.
3. Roa B.B., Dyck P.J., Marks H.G., Chance P.F., Lupski J.R. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat. Genet. 5:1993;269-273.
4. Warner L.E., Hilz M.J., Appel S.H., Killian J.M., Kolodry E.H., Karpati G.et al. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron. 17:1996;451-460.
5. Warner L.E., Mancias P., Butler I.J., McDonald C.M., Keppen L., Koob K.G.et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18:1998;382-384.
6. Simonati A., Fabrizi G.M., Pasquinelli A., Taioli F., Cavallaro T., Morbin M.et al. Congenital hypomyelination neuropathy with Ser72Leu substitution in PMP22. Neuromuscul. Disord. 9:1999;257-261.
7. Lupski J.R., de Oca-Luna R.M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B.J.et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 66:1991;219-232.
8. Raeymaekers P., Timmerman V., Nelis E., De Jonghe P., Hoogendijk J.E., Baas F.et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul. Disord. 1:1991;93-97.
9. Roa B.B., Garcia C.A., Suter U., Kulpa D.A., Wise C.A., Mueller J.et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N. Engl. J. Med. 329:1993;96-101.
10. Hayasaka K., Himoro M., Sato W., Takada G., Uyemura K., Shimizu N.et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat. Genet. 5:1993;31-34.
11. Bergoffen J., Scherer S.S., Wang S., Scott M.O., Bone L.J., Paul D.L.et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
12. Timmerman V., De Jonghe P., Ceuterick C., De Vriendt E., Lofgren A., Nelis E.et al. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology. 52:1999;1827-1832.
13. Boerkoel C.F., Takashima H., Garcia C.A., Olney R.K., Johnson J., Berry K.et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann. Neurol. 51:2002;190-201.
14. Numakura C., Lin C., Ikegami T., Guldberg P., Hayasaka K. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum. Mutat. 20:2002;392-398.
15. Aoyama M., Matsuki T., Kishi K., Iida R., Tsubota E. DYS19 marker in Japanese populations. Int. J. Legal Med. 110:1997;112-113.
16. Joseph L.J., LeBeau M.M., Jamieson G.A. Jr., Acharya S., Shows T.B., Rowley J.D.et al. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7164-7168.
17. Russo M.W., Sevetson B.R., Milbrandt J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6873-6877.
18. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6873-6877.
19. Bellone E., Di Maria E., Soriani S., Varese A., Doria L.L., Ajmar F.et al. A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum. Mutat. 14:1999;353-354.
20. Latour P., Gatignol A., Boutrand L., Nivelon-Chevallier A., Giraud M., Boucherat M.et al. A R381H mutation in the EGR2 gene associated with a severe peripheral neuropathy with hypotonia. J. Peripher. Nerv. Syst. 4:1999;293-294.
21. Pareyson D., Taroni F., Botti S., Morbin M., Baratta S., Lauria G.et al. Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology. 54:2000;1696-1698.
22. Yoshihara T., Kanda F., Yamamoto M., Ishihara H., Misu K., Hattori N.et al. A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot-Marie-Tooth disease type 1. J. Neurol. Sci. 184:2001;149-153.
23. Warner L.E., Svaren J., Milbrandt J., Lupski J.R. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum. Mol. Genet. 8:1999;1245-1251.
24. Schneider-Maunoury S., Topilko P., Seitandou T., Levi G., Cohen-Tannoudji M., Pournin S.et al. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell. 75:1993;1199-1214.
25. Swiatek P.J., Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 7:1993;2071-2084.
26. Reddy J.C., Morris J.C., Wang J., English M.A., Haber D.A., Shi Y.et al. WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270:1995;10878-10884.